What The Media Coverage Got Wrong

When the Parliamentary and Health Service Ombudsman's findings about my case finally reached the media, I should probably have felt that something enormous had happened.

After years of complaining, researching, challenging NHS policy, asking questions that repeatedly went unanswered and trying to understand how decisions affecting women's bodies had actually been made, an independent investigation had finally confirmed that many of the concerns I had been raising were justified.

The story travelled quickly. It was reported by the BBC, The Guardian, CNN, The Telegraph, LBC and numerous other publications in the UK and internationally.

I am grateful that it was reported.

But I also think that the way the story was reported created a deeply misleading impression of what had actually happened.

The Headline Version Was Much Neater Than Reality

Some of the coverage said that I had “won my case”. Some described me as having “won the right to sterilisation”. Others presented the story as a woman exposing discrimination, the Ombudsman intervening, the NHS changing its policy, and therefore the problem being fixed.

It makes a very satisfying story.

It is also not what happened.

The Parliamentary and Health Service Ombudsman investigated the decision-making behind the female sterilisation policy and the way my complaint had been handled.

Its findings were significant.

The Ombudsman found that the decision-making behind the policy had failed to appropriately balance the evidence, had not properly explored relevant evidence, had failed to clearly document why the decision departed from clinical guidance, had not dealt with comparable circumstances affecting women and men fairly and consistently, and had not been appropriately consulted on.

It also found failures in the handling of my complaint, including the failure to keep me properly informed and the failure to thoroughly address the actual concerns I had been raising.

In one of the most important passages in the report, the Ombudsman said that my views about the flawed decision-making behind the policy were right and acknowledged that I had consistently set out the evidence supporting those concerns.

That mattered enormously to me.

But the Ombudsman also explicitly said that it could not determine that I personally would have qualified for NHS-funded sterilisation if those failures had not happened.

That distinction almost disappeared from the public story.

The Parliamentary and Health Service Ombudsman Is Not A Court

This is something I do not think most members of the public understand, and I certainly did not fully appreciate the implications of it when I first entered the complaints system.

The Parliamentary and Health Service Ombudsman can investigate NHS organisations, make findings of maladministration and injustice, make recommendations, require responses and escalate serious non-compliance.

But its recommendations are not legally enforceable in the way that a court order is.

The Ombudsman itself states that it does not have legal powers to force an organisation to comply with its recommendations.

That is a very important limitation.

It is also striking when compared with the Financial Ombudsman Service. If a consumer accepts a final Financial Ombudsman decision, that decision can become legally binding on the financial business.

The Parliamentary and Health Service Ombudsman does not have the equivalent power over the NHS bodies it investigates.

So when newspapers say that somebody “won” against the NHS through the Ombudsman, the ordinary reader can quite reasonably imagine something much stronger than what has actually happened.

The Ombudsman can expose a failure.

It can recommend what should happen next.

It cannot simply order the NHS to provide me with sterilisation or force an NHS commissioning body to adopt the policy I believe patient autonomy requires.

I Did Not “Win The Right To Sterilisation”

This is probably the single most frustrating misconception created by the coverage.

I did not emerge from this process holding a legally enforceable right to walk into an NHS hospital and receive sterilisation on the basis of informed consent.

That did not happen.

What happened was that the policy was subsequently changed from “Not Normally Funded” to “Funded with Criteria”.

That was an improvement.

The previous policy had relied explicitly on supposed levels of regret and the existence of more cost-effective forms of contraception as reasons not to routinely fund female sterilisation. The revised policy removed those particular eligibility arguments.

I am not pretending that nothing changed.

But what replaced the old policy still does not resolve the fundamental issue I had been fighting about.

Under the February 2026 policy, female sterilisation is funded only where informed consent has been obtained and the woman has undergone an appropriate “therapeutic trial” of Long-Acting Reversible Contraception, or where LARC is considered contraindicated or inappropriate.

So the route remains criteria-based.

It is not simply:

That is the model I have been arguing for.

Instead, a woman seeking permanent contraception can still be placed into a pathway requiring her to trial a different form of contraception first unless clinicians decide that doing so is contraindicated or inappropriate.

That is particularly difficult for me to reconcile with the very clinical guidance discussed in the Ombudsman's report, which states that women should not feel pressured into choosing LARC over female sterilisation.

A Changed Policy Is Not Necessarily A Resolved Problem

This is where I have a serious problem with the way the NHS response was subsequently presented.

There was a lot of activity.

There were revised policies, committees, discussions, implementation dates, recommendations, reviews and assurances that learning was taking place.

Those things can sound impressive when condensed into an organisational response or a news article.

But process is not the same thing as outcome.

Changing the label from “Not Normally Funded” to “Funded with Criteria” does not automatically mean that the fundamental question of autonomy has been resolved.

To me, the critical question was never merely:

“Will you rewrite the policy?”

It was:

“Will you respect a competent woman's informed decision about permanent contraception in the same meaningful way that you respect a man's?”

As of September 2026, the policy has NOT reached that point.

The Media Mostly Reported A Closed Case

This is where the consequences of the reporting became particularly disheartening for me.

A great deal of the coverage appeared to repeat, syndicate or reframe the same basic version of events.

Very few people approached me wanting to understand the years of material underneath the headline.

Many publications reported on a case involving my body, my complaint and several years of my life without ever speaking to me about what I believed remained unresolved.

That meant the neat version travelled much further than the complicated one.

Woman denied sterilisation.

Woman complains.

Ombudsman agrees NHS got things wrong.

NHS changes policy.

Woman wins.

Story over.

Except the story was not over.

The BBC South Interview Was My Attempt To Say That Publicly

When I later spoke to BBC South, one of the most important points I wanted to raise was precisely this: despite everything that had happened, I did not believe the revised policy had created genuinely equal, consent-based access to permanent contraception.

I wanted people to understand that the distinction mattered.

When a response from the Ombudsman followed, I did not feel that it really addressed the point I was making.

To me, the response appeared to move back towards whether recommendations had been acted upon and whether the NHS had gone through the expected processes.

But that was not my question.

My question was whether the outcome of those processes had actually produced equal, autonomy-respecting access.

Those are not the same question.

The Most Painful Consequence Was That Everyone Thought It Was Finished

This is the part that makes me particularly angry about the way the story was framed.

I had spent years getting this issue into the light.

Then, when it finally became national and international news, the dominant story told the public that I had effectively won.

And afterwards, nobody from a major women's rights organisation contacted me to ask whether women actually had equal access now.

Nobody from a human rights organisation contacted me to ask whether the underlying autonomy issue had been resolved.

No major charity approached me to say, “The Ombudsman has exposed serious failings. What still needs to happen?”

At least, that was my experience.

I cannot prove who might have contacted me had the reporting been different.

But I can say that the public framing made an ongoing fight look like a completed victory.

And when a systemic problem is presented as solved, there is very little reason for anyone reading about it to mobilise around fixing it.

And This Is Where The Power Imbalance Becomes Brutal

People sometimes talk about taking the NHS to court as though it is simply the obvious next stage.

But look at the reality of that.

I am one individual.

On the other side is a publicly funded healthcare system with enormous institutional resources, legal teams, governance structures and access to expertise.

An Ombudsman investigation can expose maladministration, but if the resulting recommendations do not produce the substantive change a patient believes is required, enforceable change may ultimately require legal proceedings.

And legal proceedings require resources.

England and Wales do have mechanisms for litigation involving multiple claimants, including Group Litigation Orders and representative proceedings. But there is no simple, general-purpose US-style class action through which I can announce that every woman affected by this kind of policy is automatically part of one case and then take the NHS on collectively.

Group litigation has its own procedural requirements, legal tests, individual claims, funding questions and potential costs.

So unless a law firm, insurer, funder, charity or campaigning organisation is prepared to support a case, much of the practical and financial burden of forcing the issue through the courts can still land on individual patients.

That is an extraordinary imbalance of power.

The system can make a decision affecting thousands of people using public money.

The individual affected by that decision may then have to find their own time, energy, expertise and money to challenge it.

My View Of The Institutional Conduct Is Much Harsher Than The Headlines Suggested

The media story understandably concentrated on contraception and the difference between female sterilisation and vasectomy.

But after living through this process, one of my biggest concerns is no longer simply contraception policy.

It is integrity.

I have spent years trying to establish who made decisions, what evidence those decisions were based upon, who was responsible for checking them, why questions were not answered and what happened when serious failures were eventually identified.

I have received formal assurances about processes and governance that, in my view, became extremely difficult to reconcile with the documentary record and with what the Ombudsman subsequently found.

I have repeatedly experienced responsibility disappearing into committees, departments, organisational structures and carefully worded correspondence.

My personal view of some of that conduct is not polite.

There have been times when I have experienced what I was being told as dishonest. There have been times when I have described what I was seeing as cover-up, institutional defensiveness or an attempt to make serious failures disappear into procedure.

Those are my characterisations of my experience.

I am publishing the underlying documents precisely because I do not expect anybody to accept those words simply because I use them.

Read the correspondence.

Read what I asked.

Read what I was told.

Read what the Ombudsman later established.

Then decide for yourself whether my anger is justified.

After this experience, my opinion is that I have encountered people and structures that have at times behaved as though patient rights, bodily autonomy and accountability were problems to be managed rather than responsibilities to be protected.

That is an opinion readers are entirely free to disagree with.

But public officials and healthcare leaders are entrusted with extraordinary responsibility for other people's health and lives. I believe their conduct should be capable of equally extraordinary scrutiny.

The Ombudsman's Own Findings Were More Damning Than The “Victory” Story Suggests

Ironically, describing this simply as a successful complaint can make the actual findings sound less serious.

The Ombudsman did not merely say that somebody had filled in a form incorrectly.

It found that the policy-making process had failed to appropriately balance evidence, failed to explain departures from clinical guidance, failed to deal fairly and consistently with comparable male and female sterilisation policy, and had not been appropriately consulted upon.

It found the ICB had not properly addressed the substance of my complaint.

It explicitly recognised the emotional impact of repeatedly having to pursue answers and of being left with the feeling that I was being treated as though I was not competent to make decisions about my own body.

And importantly, the report stated that, without those failings, it was more likely than not that the eligibility criteria would have been different.

That is not a trivial finding.

It raises questions far beyond my individual case.

How Many Other Women Were Affected?

This is one of the questions I still think deserves far more attention.

The policy did not apply only to me.

For years, other women living under the same commissioning arrangements were potentially encountering the same restrictions.

Most of them will never file an Ombudsman complaint.

Most will never read committee papers from 2017.

Most will never submit Freedom of Information requests, analyse commissioning policy, compare male and female pathways, challenge NHS governance or spend years trying to establish who was responsible.

They may simply have been told no.

And then gone home.

That is why I do not regard this as merely “my case”.

This Is Why I Built The Archive

If the original media coverage gave you the impression that everything was resolved, I encourage you to go further.

This website exists so that the case does not have to remain trapped inside a two-minute news report or a newspaper article.

The Chronicles tell the story step by step.

The Evidence Archive contains the underlying policies, correspondence, complaints, Freedom of Information material, investigation documents and subsequent escalations.

The Podcast offers a conversational way to follow the chronology if you would rather listen than work through the written record.

You do not have to accept my interpretation.

In fact, I would prefer that people investigate it.

If You Are A Journalist, Please Talk To Me

If you are reporting on this story now, I would ask you not to simply reproduce the headline version that appeared in May 2026.

There is much more to this case.

There is the original policy.

There is the evidence behind it.

There is the Ombudsman investigation.

There is what the NHS said it would change.

There is what it actually changed.

And there is everything that happened when I continued asking who was accountable after the news cycle had moved on.

If you want to interview me, ask questions about the evidence or investigate the story further, please visit the Contact page.

If You Want To Use This Evidence To Challenge The System, Please Do

I also want this material to be useful beyond journalism.

If you are a lawyer, researcher, campaigner, patient advocate, healthcare professional, regulator, women's rights organisation or somebody who has experienced something similar, I want you to examine what is here.

If the evidence is relevant to a complaint, investigation, legal challenge, policy review, academic work or public-interest campaign, follow it.

If a legal team believes this material can support women who were affected by the same or similar policies, I want them to look at it.

If somebody believes the conduct documented here warrants further regulatory, governance or legal scrutiny, scrutinise it.

You can read more about my position on the legitimate public-interest use of material from this archive on the Fair Use & Public Interest page.

The Story Is Still Open

The media coverage gave this case visibility, and I will always be grateful for that.

But visibility and understanding are not the same thing.

A simplified victory narrative may actually have taken urgency away from the very issue the investigation had finally exposed.

I cannot undo that coverage.

What I can do is publish the rest of the story.

The documents are here.

The chronology is here.

The questions are still here.

And so am I.